Comparison of Functional Status, Electrocardiographic, and Echocardiographic Parameters to Mortality in Endomyocardial-Biopsy Proven Cardiac Amyloidosis

American Journal of Cardiology

Volumn 103, Issue 10, 2009, Pages 1429-1433

  Austin, Bethany A ^a   Duffy, Brendan ^a   Tan, Carmela ^a   Rodriguez, E Rene ^a   Starling, Randall C ^a   Desai, Milind Y ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FUNCTIONAL STATUS; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE BIOPSY; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL TIME;

AGED; AMYLOIDOSIS; BIOPSY; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 65449155091     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.361     Document Type: Article

References (18)

1. Cueto-Garcia L., Reeder G.S., Kyle R.A., Wood D.L., Seward J.B., Naessens J., Offord K.P., Greipp P.R., Edwards W.D., and Tajik A.J. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6 (1985) 737-743
2. Falk R.H. Diagnosis and management of the cardiac amyloidoses. Circulation 112 (2005) 2047-2060
3. Grogan M., Gertz M.A., Kyle R.A., and Tajik A.J. Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 85 (2000) 664-665
4. Selvanayagam J.B., Hawkins P.N., Paul B., Myerson S.G., and Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50 (2007) 2101-2110
5. Koyama J., Ray-Sequin P.A., and Falk R.H. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation 106 (2002) 556-561
6. Klein A.L., Hatle L.K., Taliercio C.P., Oh J.K., Kyle R.A., Gertz M.A., Bailey K.R., Seward J.B., and Tajik A.J. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 83 (1991) 808-816
7. Roberts W.C., and Waller B.F. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 52 (1983) 137-146
8. Patel A.R., Dubrey S.W., Mendes L.A., Skinner M., Cupples A., Falk R.H., and Davidoff R. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol 80 (1997) 486-492
9. Cueto-Garcia L., Tajik A.J., Kyle R.A., Edwards W.D., Greipp P.R., Callahan J.A., Shub C., and Seward J.B. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 59 (1984) 589-597
10. Tei C., Dujardin K.S., Hodge D.O., Kyle R.A., Tajik A.J., and Seward J.B. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 28 (1996) 658-664
11. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 26 (1995) 135-136
12. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., Tajik A.J., and Seward J.B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 26 (1995) 357-366
13. Kristen A.V., Perz J.B., Schonland S.O., Hegenbart U., Schnabel P.A., Kristen J.H., Goldschmidt H., Katus H.A., and Dengler T.J. Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 9 (2007) 617-624
14. Siegel R.J., and Roberts W.C. Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient. Am Heart J 103 (1982) 210-221
15. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., and Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
16. Carroll J.D., Gaasch W.H., and McAdam K.P. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol 49 (1982) 9-13
17. Jones R.C., Francis G.S., and Lauer M.S. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 44 (2004) 1025-1029
18. Pocock S.J., Wang D., Pfeffer M.A., Yusuf S., McMurray J.J.V., Swedberg K.B., Ostergren J., Michelson E.L., Pieper K.S., Granger C.B., and CHARM investigators. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27 (2006) 65-75